The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

Podobné jednotky

• Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations
  Autor: Kadouri, Luna, a další
  Vydáno: (2007)
• Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
  Autor: Friedman, E, a další
  Vydáno: (1998)
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
  Autor: Abeliovich, D, a další
  Vydáno: (1997)
• Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
  Autor: Hamel, Nancy, a další
  Vydáno: (2003)
• Modeling the Probability That Ashkenazi Jewish Women Carry a Founder Mutation in BRCA1 or BRCA2
  Autor: Hopper, John L., a další
  Vydáno: (1999)